ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 309401 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 309401; 2) Community: the network communities that were significantly associated with the response to NSC 309401; 3) Molecule: the relationships between components within communities and NSC 309401; 4) MDR: the compounds that were significantly associated with the NSC 309401.

NSC Compound Enrichment Correlation
NSC 349447 Indolo[2,1-b]quinazoline-6,12-dione (8CI9CI) 0.00347157511980532 0.46978855
NSC 529108 4-Fluoro-D,L-tryptophan 0.00347157511980532 0.40224497
NSC 58905 9H-Purine, 9-(2-chloroethyl)-6-[(phenylmethyl)thio]- (9CI) 0.00347157511980532 0.43067523
NSC 602313 Null 0.00347157511980532 0.72591229
NSC 610456 Camptothecin Derivative 0.00347157511980532 0.54899256
NSC 628000 Null 0.00347157511980532 0.02927015
NSC 631451 Null 0.00347157511980532 0.24727403
NSC 637008 Null 0.00347157511980532 0.16112841
NSC 661746 2-Debenzoyl-2-(3',5'-difluorobenzoyl)-15(16)-anhydro-11(15->1)-abeotaxol 0.00347157511980532 0.39026374
NSC 668281 (-)-.beta.-L-1-[(2-Hydroxymethyl)-1,3-dioxolan-4yl]cytosine 0.00347157511980532 0.47769045
Total:144  Current:19    [First] [Prev] [Next] [Last]